Diagnostic imaging

The Lancet

Volumn 379, Issue 9825, 2012, Pages 1525-1533

  Morris, Peter ^a   Perkins, Alan ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CRYSTAL STRUCTURE; CYCLOTRON; DIAGNOSTIC IMAGING; DOPPLER FLOWMETRY; ELECTROENCEPHALOGRAPHY; GAMMA RADIATION; MAGNETOENCEPHALOGRAPHY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; NUCLEAR REACTOR; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY RADIATION; RADIOGRAPHY; ULTRASOUND; X RAY DIFFRACTION;

EID: 84859923479     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)60429-2     Document Type: Review

References (79)

1. Wells PNT. Physics and engineering: milestones in medicine. Med Eng Phys 2001; 23: 147-53.
2. Editorial. Looking back on the millennium in medicine. N Engl J Med 2000; 342: 42-49.
3. Christie DA, Tansey EM, eds. Wellcome Witnesses to Twentieth Century Medicine. Volume 28. Development of physics applied to medicine in the UK 1945-1990. London: Wellcome Trust Centre for the History of Medicine at UCL, 2006.
4. Röntgen WC. Uber eine neue Art von Strahlen (Vorlaufige Mitteilung). Sber Physik-med Ges Wurzburg 1895; 9: 132-41.
5. Mould RF. The early history of X-ray diagnosis with emphasis on the contributions of physics 1895-1915. Phys Med Biol 1995; 40: 1741-87.
6. Coolidge WD. A powerful roentgen ray tube with a pure electron discharge. Phys Rev 1913; 2: 409.
7. Hounsfield GN. Computerized transverse axial scanning (tomography) I. Description of system. Br J Radiol 1973; 46: 1016-22.
8. Radon J. On the determination of functions from their integral values along certain manifolds. IEEE Trans Med Imaging 1986; 5: 170-76.
9. Cormack AM. Representation of a function by its line integrals with some radiological applications. J Appl Phys 1963; 34: 2722-27.
10. Cormack AM. Representation of function by its line integrals with some radiological applications. J Appl Clin Med Phys 1964; 35: 2908-13.
11. Paxton R, Ambrose J. EMI scanner\brief review of first 650 patients. Br J Radiol 1974; 47: 530-65.
12. Wijesekera NT, Duncan MK, Padley SPG. X-ray computed tomography of the heart. Br Med Bull 2010; 93: 49-67.
13. Herman GT. Fundamentals of computerized tomography: image reconstruction from projection, 2nd edn. London: Springer-Verlag, 2009.
14. Kalender WA. X-ray computed tomography. Phys Med Biol 2006; 51: R29-43.
15. Eisenberg RL. Clinical imaging: an atlas of diff erential diagnosis, 5th edn. Philadelphia: Lipincott, Williams and Wilkins, 2010.
16. Carlsson S. A glance at history of nuclear medicine. Acta Oncol 1995; 34: 1095-102.
17. Chiewitz O, de Hevesy G. Radioactive indicators in the study of phosphorus metabolism in rats. Nature 1935; 136: 439.
18. Cassen B, Curtis L, Reed A, Libby RL. Instrumentation for I-131 use in medical studies. Nucleonics 1951; 9: 46-49.
19. Anger HO. A new instrument for mapping gamma-ray emitters. Biol Med Quart Rep UCRL 1957; 3653: 38.
20. Harper PV, Andros G, Lathrop K, Siemens W, Weiss L. Technetium-99 as a biological tracer. J Nucl Med 1962; 3: 209.
21. Perkins AC, Vivian G. Molybdenum supplies and nuclear medicine services. Nuclear Med Commun 2009; 30: 657-59.
22. Kuhl DE, Edwards RQ. Image separation radioisotope scanning. Radiology 1963; 80: 653-62.
23. Larsson SA. Gamma camera emission tomography. Development and properties of a multi-sectional emission computed tomography system. Acta Radiol Suppl 1980; 363: 1-75.
24. Ingvar DH, Lassen NA. Quantitative determination of regional cerebral blood flow in man. Lancet 1962; 278: 806-07.
25. Love WD, Romney RB, Burch GE. A comparison of the distribution of potassium and exchangeable rubidium in the organs of the dog using rubidium-86. Circ Res 1954; 2: 112-22.
26. Strauss HW, Harrison K, Langan JK, Lebowitz E, Pitt B. Th-201 for myocardial imaging. Relation of Th-201 to regional myocardial perfusion. Circulation 1975; 51: 641-45.
27. Subraman.G, McAfee JG. New complex of Tc-99m for skeletal imaging. Radiology 1971; 99: 192-96.
28. Tobias CA, Lawrence JH, Roughton FJW, Root WS, Gregersen MI. The elimination of carbon monoxide from the human body with reference to the possible conversion of CO to CO2. Am J Physiol 1945; 145: 253-63.
29. Sweet WH. The use of nuclear disintegration in diagnosis and treatment of brain tumors. N Engl J Med 1951; 245: 875-78.
30. Wrenn FRJ. The use of positron emitting radioisotopes for localization of brain tumors. Science 1951; 113: 525-27.
31. Phelps ME, Hoff man EJ, Mullani NA, Higgins CS, Terpogossian MM. Design considerations for a positron emission transaxial tomograph (PETT III). IEEE Trans Nucl Sci 1976; 23: 516-22.
32. Hoff man EJ, Phelps ME, Mullani NA, Higgins CS, Terpogossian MM. Design and performance-characteristics of a whole-body positron transaxial tomograph. J Nucl Med 1976; 17: 493-502.
33. Jones TA. A brief history of positron-emitting tracers and positron emission tomography in medicine. In: Valk PE, ed. Positron Emission Tomography: basic science and clinical practice. New York: Springer, 2003: 4-40.
34. Toga AW, Mazziotta JC. Brain mapping: the methods. Amsterdam: Elsevier, 1996.
35. Plathow C, Weber WA. Tumor cell metabolism imaging. J Nucl Med 2008; 49: S43-63.
36. UK RCoPot. Positron emission tomography: a strategy for provision in the UK. London: Royal College of Physicians, 2003.
37. Facey K, Bradbury I, Laking G, Payne E. Overview of the clinical effectiveness of positron emission tomography imaging in selected cancers. Health Technol Assess 2007; 11: iii-iv, xi-267.
38. Hillner BE, Siegel BA, Shields AF, et al. The impact of positron emission tomography (PET) on expected management during cancer treatment. Cancer 2009; 115: 410-18.
39. Johnson KA, Gregas M, Becker JA, et al. Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol 2007; 62: 229-34.
40. Lauterbur PC. Image formation by induced local interactions\examples employing nuclear magnetic-resonance. Nature 1973; 242: 190-91.
41. Mansfield.P, Grannell PK. NMR diff raction in solids. J Phys Condens Matter 1973; 6: L422-26.
42. Mansfield P, Maudsley AA. Medical imaging by NMR. Br J Radiol 1977; 50: 188-94.
43. Damadian R, Goldsmith M, Minkoff L. NMR in cancer XVI. FONAR image of the live human body. Physiol Chem Phys 1997; 9: 97-100.
44. Mansfield P, Pykett IL, Morris PG, Coupland RE. Human whole-body line-scan imaging by NMR. Br J Radiol 1978; 51: 921-22.
45. Edelman RR, Hesselink JR, Zlatkin MB, Crues JV. Clinical Magnet Resonance Imaging, 3rd edn: New York: Elsevier, 2006.
46. Damadian R. Tumor detection by nuclear magnetic resonance. Science 1971; 171: 1151-57.
47. Young IR, Hall AS, Pallis CA, Legg NJ, Bydder GM, Steiner RE. Nuclear magnetic resonance imaging of the brain in multiple sclerosis. Lancet 1981; 2: 1063-66.
48. Smith F W, Mallard JR, Hutchison JMS, et al. Clinical-application of nuclear magnetic-resonance. Lancet 1981; 317: 78-79.
49. Tallantyre EC, Morgan PS, Dixon JE, et al. A comparison of 3T and 7T in the detection of small parenchymal veins within MS lesions. Invest Radiol 2009; 44: 491-94.
50. Mansfield P. Multi-planar image-formation using nmr spin echoes. J Phys Condens Matter 1977; 10: L55-58.
51. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology 2006; 238: 42-53.
52. Neumann-Haefelin T, Wittsack HJ, Wenserski F, et al. Diff usion-and perfusion-weighted MRI. The DWI/PWI mismatch region in acute stroke. Stroke 1999; 30: 1591-97.
53. Cabeza R, Kingstone A. Handbook of functional neuroimaging of cognition. Cambridge, MA: MIT Press, 2006.
54. Yacoub E, Harel N, Ugurbil K. High-field fMRI unveils orientation columns in humans. Proc Natl Acad Sci USA 2008; 105: 10607-12.
55. Le Bihan D, Mangin JF, Poupon C, et al. Diff usion tensor imaging: concepts and applications. J Magn Reson Imaging 2001; 13: 534-46.
56. Ardenkjaer-Larsen JH, Fridlund B, Gram A, et al. Increase in signal-to-noise ratio of > 10,000 times in liquid-state NMR. Proc Natl Acad Sci USA 2003; 100: 10158-63.
57. Moller HE, Chen XJ, Saam B, et al. MRI of the lungs using hyperpolarized noble gases. Magn Reson Med 2002; 47: 1029-51.
58. Berger H. Electroencephalogram in humans. Archiv Fur Psychiatrie Und Nervenkrankheiten 1929; 87: 527-70.
59. Cohen D. Magnetoencephalography\evidence of magnetic fields produced by alpha-rhythm currents. Science 1968; 161: 784-87.
60. Hamalainen M, Hari R, Ilmoniemi RJ, Knuutila J, Lounasmaa OV. Magnetoencephalography\theory, instrumentation, and applications to noninvasive studies of the working human brain. Rev Mod Phys 1993; 65: 413-97.
61. VanVeen BD, vanDrongelen W, Yuchtman M, Suzuki A. Localization of brain electrical activity via linearly constrained minimum variance spatial filtering. IEEE Trans Biomed Eng 1997; 44: 867-80.
62. Brookes MJ, Zumer JM, Stevenson CM, et al. Investigating spatial specificity and data averaging in MEG. Neuroimage 2010; 49: 525-38.
63. Fisher AE, Furlong PL, Seri S, et al. Interhemispheric diff erences of spectral power in expressive language: a MEG study with clinical applications. Int J Psychophysiol 2008; 68: 111-22.
64. Rumack CM, Wilson SR, Charboneau JW, Johnson J-A. A diagnostic ultrasound, 4th edn. Philadelphia: Mosby, 2011.
65. Donald I, Macvicar J, Brown TG. Investigation of abdominal masses by pulsed ultrasound. Lancet 1958; 271: 1188-94.
66. Phillips RA, Stratmeyer ME, Harris GR. Safety and US regulatory considerations in the non-clinical use of medical ultrasound devices. Ultrasound Med Biol 2010; 36: 1224-28.
67. Houston LE, Odibo AO, Macones GA. The safety of obstetrical ultrasound: a review. Prenatal Diagn 2009; 29: 1204-12.
68. Burns PN. Harmonic imaging with ultrasound contrast agents. Clin Radiol 1996; 51: 50-55.
69. Tranquart F, Grenier N, Eder V, Pourcelot L. Clinical use of ultrasound tissue harmonic imaging. Ultrasound Med Biol 1999; 25: 889-94.
70. Quaia E. Microbubble ultrasound contrast agents: an update. Eur Radiol 2007; 17: 1995-2008.
71. Deshpande N, Needles A, Willmann JK. Molecular ultrasound imaging: current status and future directions. Clin Radiol 2010; 65: 567-81.
72. Ward JF. High-intensity focused ultrasound for therapeutic tissue ablation in surgical oncology. Surg Oncol Clin N Am 2011; 20: 389-407.
73. Williams AK, Martinez CH, Chalasani V, Chin J. High-intensity focused ultrasound: where are we and where to from here? Expert Rev Anticancer Ther 2010; 10: 33-40.
74. Crouzet S, Murat FJ, Pasticier G, Cassier P, Chapelon J Y, Gelet A. High intensity focused ultrasound (HIFU) for prostate cancer: current clinical status, outcomes and future perspectives. Int J Hyperthermia 2010; 26: 796-803.
75. Elahi SF, Wand TD. Future and advances in endoscopy. J Biophotonics 2011; 4: 471-81.
76. Simpson DR, Lawson JD, Nath SK, Rose BS, Mundt AJ, Mell LK. A survey of image-guided radiation therapy use in the United States. Cancer 2010; 116: 3953-60.
77. Low DA, Moran JM, Dempsey JF, Dong L, Oldham M. Dosimetry tools and techniques for IMRT. Med Phys 2011; 38: 1313-38.
78. Sterzing F, Engenhart-Cabillic R, Flentje M, Debus J. Image-guided radiotherapy a new dimension in radiation oncology. Dtsch Arztebl Int 2011; 108: 274-80.
79. Sutherland GR, Latour I, Greer AD, et al. An image-guided magnetic resonance-compatible surgical robot. Neurosurgery 2008; 62: 286-92.